Richard Bartram

Insider Reports History

Location
Ann Arbor, MI
Signature
/s/ Richard Bartram
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Bartram:

Company Role Class Num Shares Value Price $ Report Date Ownership
Esperion Therapeutics, Inc. Chief Financial Officer Common Stock 82,751 $103,025 $1.24 14 Mar 2022 Direct
Esperion Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy 159,000 14 Mar 2022 Direct
MBX Biosciences, Inc. Chief Financial Officer Stock Option (Right to Buy) 95,000 03 Feb 2025 Direct

Insider Reports Filed by Richard Bartram

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MBX MBX Biosciences, Inc. 03 Feb 2025 1 $0 4 Chief Financial Officer 05 Feb 2025, 16:17
MBX MBX Biosciences, Inc. 12 Sep 2024 1 $0 4 Chief Financial Officer 13 Sep 2024, 17:13
MBX MBX Biosciences, Inc. 12 Sep 2024 0 $0 3 Chief Financial Officer 12 Sep 2024, 19:09
ESPR Esperion Therapeutics, Inc. 14 Mar 2022 1 $0 4 Chief Financial Officer 16 Mar 2022, 17:09
ESPR Esperion Therapeutics, Inc. 29 Oct 2021 1 $0 4 Chief Financial Officer 01 Nov 2021, 16:48
ESPR Esperion Therapeutics, Inc. 28 Jun 2021 2 $0 4 Chief Financial Officer 30 Jun 2021, 16:27